A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients

Clinical trial NCT02569372 · COMPLETED

Trial details

NCT number: NCT02569372
Sponsor: Green Cross Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2015-11-09
Primary completion: 2017-10-12
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.